Citation Study nation(s) Study type Study year(s) Drug Mean age (years) Final cures Final failures LTFU PKDL % treatment failures (95% CI)
[@17653] India Cohort 2005* SSG N/A 65 24 0 0 27.0 (18.1-37.4)
[@17672] India RCT 1993-1995 SSG 26.1 19 3 0 0 13.6 (2.9-34.9)
[@17679] Kenya RCT 1997-1998 SSG 9.0 52 6 35 0 10.3 (3.9-21.2)
[@17690] Sudan, Ethiopia, Kenya RCT 2004-2010 SSG 15.3 524 32 0 0 5.8 (4.0-8.0)
[@17682] Nepal Cohort 1999-2001 SSG 23.8 98 1 4 0 1.01 (0.0-5.5)
[@17689] Nepal Cohort 2001-2003 SSG 23.9† 153 16 12 0 9.5 (5.5-14.9)
[@17670] India RCT 1992-1993 SSG 27.0 9 2 0 0 18.2 (2.3-51.8)
[@17671] India RCT 1995-1996 SSG 20.0 18 2 0 0 10.0 (1.2-31.7)
[@17676] India Cohort 1994-1997 SSG 22.5 168 15 6 0 8.2 (4.7-13.2)
[@17692] India Cohort 1994-1996 SSG 25.2 46 2 0 0 4.2 (0.5-14.3)
[@17652] India RCT 1996 SSG 22.4 26 1 0 0 3.7 (0.1-19.0)
[@17677] India RCT 1996 SSG 27.9 21 1 0 0 4.5 (0.1-22.8)
[@17683] India Cohort 2000-2001 SSG 35.0† 24 6 0 0 20.0 (7.7-38.6)
[@17684] India Cohort 2000-2002 SSG 28.0 39 8 0 0 17.0 (7.7-30.8)
[@17648] India RCT 2004-2005 SSG 34.0† 25 5 0 0 16.7 (5.6-34.7)
[@17667] Sudan RCT 1989-1990 SSG 15.0 21 1 2 1 4.2 (0.1-21.1)